Enriching and characterizing cancer stem cell sub-populations in the WM115 melanoma cell line

Biomaterials

Volumn 32, Issue 35, 2011, Pages 9316-9327

  Chandrasekaran, Siddarth ^a   DeLouise, Lisa A ^a,b  

^a University of Rochester   (United States)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Cancer stem cell; Cell morphology; Flow cytometry; Microbubble arrays; Polydimethylsiloxane

Indexed keywords

BASAL LAYER; CANCER CHEMOTHERAPEUTICS; CANCER STEM CELLS; CELL MARKERS; CELL MORPHOLOGY; CIRCULAR OPENING; CLONOGENIC POTENTIAL; FLOW-CYTOMETRIC ANALYSIS; GAS EXPANSION; IN-VITRO; MELANOMA CELLS; METASTATIC MELANOMA; MICRO-BUBBLE; MICROBUBBLES; POLYDIMETHYLSILOXANE PDMS; SPHERICAL CAVITIES; SUB-POPULATIONS; THERAPEUTIC STRATEGY; TISSUE CULTURE PLATES;

CELL PROLIFERATION; CYTOLOGY; DERMATOLOGY; DISEASES; FLOW CYTOMETRY; MICROCHANNELS; MONOLAYERS; ONCOLOGY; POLYDIMETHYLSILOXANE; SILICONES; STEM CELLS; TISSUE CULTURE; TUMORS; WELLS;

CLONE CELLS;

ADAPALENE; CD20 ANTIGEN; DIMETICONE;

ARTICLE; CANCER CELL CULTURE; CANCER STEM CELL; CELL PROLIFERATION; CELL SUBPOPULATION; CLONOGENESIS; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; MELANOMA CELL; MICROBUBBLE; PHENOTYPE; PRIORITY JOURNAL; SPHEROID CELL; SURVIVAL; TISSUE CULTURE;

ANTIGENS, CD20; CELL ADHESION; CELL LINE, TUMOR; CELL SHAPE; CELL SURVIVAL; DIMETHYLPOLYSILOXANES; HUMANS; MELANOMA; MICROBUBBLES; NAPHTHALENES; NEOPLASTIC STEM CELLS; PHENOTYPE; POLYSTYRENES; SPHEROIDS, CELLULAR; TUMOR MARKERS, BIOLOGICAL; TUMOR STEM CELL ASSAY;

EID: 80053586430     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2011.08.056     Document Type: Article

References (57)

1. Fidler I.J. The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat Rev Cancer 2003, 3(6):453-458.
2. Chang Y.S., di Tomaso E., McDonald D.M., Jones R., Jain R.K., Munn L.L. Mosaic blood vessels in tumors: frequency of cancer cells in contact with flowing blood. Proc Natl Acad Sci U S A 2000, 97(26):14608-14613.
3. Zhou B.B., Zhang H., Damelin M., Geles K.G., Grindley J.C., Dirks P.B. Tumour-initiating cells: challenges and opportunities for anticancer drug discovery. Nat Rev Drug Discov 2009, 8(10):806-823.
4. Held M.A., Curley D.P., Dankort D., McMahon M., Muthusamy V., Bosenberg M.W. Characterization of melanoma cells capable of propagating tumors from a single cell. Cancer Res 2010, 70(1):388-397.
5. Ireland A., Millward M., Pearce R., Lee M., Ziman M. Genetic factors in metastatic progression of cutaneous melanoma: the future role of circulating melanoma cells in prognosis and management. Clin Exp Metastasis 2011, 28(4):327-336.
6. Schatton T., Frank M.H. Cancer stem cells and human malignant melanoma. Pigment Cell Melanoma Res 2008, 21(1):39-55.
7. Fang D., Nguyen T.K., Leishear K., Finko R., Kulp A.N., Hotz S., et al. A tumorigenic subpopulation with stem cell properties in melanomas. Cancer Res 2005, 65(20):9328-9337.
8. Schatton T., Murphy G.F., Frank N.Y., Yamaura K., Waaga-Gasser A.M., Gasser M., et al. Identification of cells initiating human melanomas. Nature 2008, 451(7176):345-349.
9. Boiko A.D., Razorenova O.V., van de Rijn M., Swetter S.M., Johnson D.L., Ly D.P., et al. Human melanoma-initiating cells express neural crest nerve growth factor receptor CD271. Nature 2010, 466(7302):133-137.
10. Schmidt P., Kopecky C., Hombach A., Zigrino P., Mauch C., Abken H. Eradication of melanomas by targeted elimination of a minor subset of tumor cells. Proc Natl Acad Sci U S A 2011, 108(6):2474-2479.
11. Yang A.S., Chapman P.B. The history and future of chemotherapy for melanoma. Hematol Oncol Clin North Am 2009, 23(3):583-597.
12. DiFronzo L.A., Wanek L.A., Elashoff R., Morton D.L. Increased incidence of second primary melanoma in patients with a previous cutaneous melanoma. Ann Surg Oncol 1999, 6(7):705-711.
13. Cummins D.L., Cummins J.M., Pantle H., Silverman M.A., Leonard A.L., Chanmugam A. Cutaneous malignant melanoma. Mayo Clin Proc 2006, 81(4):500-507.
14. Bates R.C., Edwards N.S., Yates J.D. Spheroids and cell survival. Crit Rev Oncol Hematol 2000, 36(2-3):61-74.
15. Sodek K.L., Ringuette M.J., Brown T.J. Compact spheroid formation by ovarian cancer cells is associated with contractile behavior and an invasive phenotype. Int J Cancer 2009, 124(9):2060-2070.
16. Monzani E., Facchetti F., Galmozzi E., Corsini E., Benetti A., Cavazzin C., et al. Melanoma contains CD133 and ABCG2 positive cells with enhanced tumourigenic potential. Eur J Cancer 2007, 43(5):935-946.
17. Mueller-Klieser W. Three-dimensional cell cultures: from molecular mechanisms to clinical applications. Am J Physiol 1997, 273(4 Pt 1):C1109-C1123.
18. Minchinton A.I., Tannock I.F. Drug penetration in solid tumours. Nat Rev Cancer 2006, 6(8):583-592.
19. Ramgolam K., Lauriol J., Lalou C., Lauden L., Michel L., de la Grange P., et al. Melanoma spheroids grown under neural crest cell conditions are highly plastic migratory/invasive tumor cells endowed with immunomodulator function. PLoS ONE 2011, 6(4):e18784.
20. Perego M., Alison M.R., Mariani L., Rivoltini L., Castelli C. Spheres of influence in cancer stem cell biology. J Invest Dermatol 2011, 131(2):546-547.
21. Perego M., Tortoreto M., Tragni G., Mariani L., Deho P., Carbone A., et al. Heterogeneous phenotype of human melanoma cells with in vitro and in vivo features of tumor-initiating cells. J Invest Dermatol 2010, 130(7):1877-1886.
22. Quintana E., Shackleton M., Sabel M.S., Fullen D.R., Johnson T.M., Morrison S.J. Efficient tumour formation by single human melanoma cells. Nature 2008, 456(7222):593-598.
23. Quintana E., Shackleton M., Foster H.R., Fullen D.R., Sabel M.S., Johnson T.M., et al. Phenotypic heterogeneity among tumorigenic melanoma cells from patients that is reversible and not hierarchically organized. Cancer Cell 2010, 18:510-523.
24. Schatton T., Frank M.H. The in vitro spheroid melanoma cell culture assay: cues on tumor initiation?. J Invest Dermatol 2010, 130(7):1769-1771.
25. Kubick B.J., Roop D.R. A fitness model for melanoma-initiating cells. Pigment Cell Melanoma Res 2011, 24:396-400.
26. Hamburger A.W., Salmon S.E. Primary bioassay of human tumor stem cells. Science 1977, 197(4302):461-463.
27. Yeung T.M., Gandhi S.C., Wilding J.L., Muschel R., Bodmer W.F. Cancer stem cells from colorectal cancer-derived cell lines. Proc Natl Acad Sci U S A 2010, 107(8):3722-3727.
28. Pastrana E., Silva-Vargas V., Doetsch F. Eyes wide open: a critical review of sphere-formation as an assay for stem cells. Cell Stem Cell 2011, 8(5):486-498.
29. Civenni G., Walter A., Kobert N., Mihic-Probst D., Zipser M., Belloni B., et al. Human CD271-positive melanoma stem cells associated with metastasis establish tumor heterogeneity and long-term growth. Cancer Res 2011, 71(8):3098-3109.
30. Welte Y., Adjaye J., Lehrach H.R., Regenbrecht C.R. Cancer stem cells in solid tumors: elusive or illusive?. Cell Commun Signal 2010, 8(1):6.
31. Singh S.K., Clarke I.D., Terasaki M., Bonn V.E., Hawkins C., Squire J., et al. Identification of a cancer stem cell in human brain tumors. Cancer Res 2003, 63(18):5821-5828.
32. Giang U.B.T., Lee D., King M.R., DeLouise L.A. Microfabrication of cavities in polydimethylsiloxane using DRIE silicon molds. Lab Chip 2007, 7(12):1660-1662.
33. Bissell M.J., Labarge M.A. Context, tissue plasticity, and cancer: are tumor stem cells also regulated by the microenvironment?. Cancer Cell 2005, 7(1):17-23.
34. Ghotra V.P., Puigvert J.C., Danen E.H. The cancer stem cell microenvironment and anti-cancer therapy. Int J Radiat Biol 2009, 85(11):955-962.
35. Chandrasekaran S., Giang U.B., King M.R., Delouise L.A. Microenvironment induced spheroid to sheeting transition of immortalized human keratinocytes (HaCaT) cultured in microbubbles formed in polydimethylsiloxane. Biomaterials 2011, 32(29):7159-7168.
36. Giang U.B.T., King M.R., DeLouise L.A. Microfabrication of bubbular cavities in PDMS for cell sorting and microcell culture applications. J Bionic Eng 2008, 5(4):308-316.
37. Janmey P.A., Miller R.T. Mechanisms of mechanical signaling in development and disease. J Cell Sci 2011, 124(Pt 1):9-18.
38. Fedoroff S and Richardson A. Colony cultures - plating efficiency assay and cloning, in protocols for neural cell culture 2001:307-315; Humana Press, doi:10.1385/1-59259-207-4.
39. Hu Y., Smyth G.K. ELDA: extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays. J Immunol Methods 2009, 347(1-2):70-78.
40. Vaillant F., Asselin-Labat M.L., Shackleton M., Forrest N.C., Lindeman G.J., Visvader J.E. The mammary progenitor marker CD61/beta3 integrin identifies cancer stem cells in mouse models of mammary tumorigenesis. Cancer Res 2008, 68(19):7711-7717.
41. Vermeulen L., Todaro M., de Sousa Mello F., Sprick M.R., Kemper K., Perez Alea M., et al. Single-cell cloning of colon cancer stem cells reveals a multi-lineage differentiation capacity. Proc Natl Acad Sci U S A 2008, 105(36):13427-13432.
42. Moreau J.F., Miller R.G. Growth at limiting dilution of human T cell colonies from T cell-depleted peripheral blood leukocytes. J Immunol 1983, 130(3):1139-1145.
43. Seo J.H., Matsuno R., Takai M., Ishihara K. Cell adhesion on phase-separated surface of block copolymer composed of poly(2-methacryloyloxyethyl phosphorylcholine) and poly(dimethylsiloxane). Biomaterials 2009, 30(29):5330-5340.
44. Groth T., Altankov G. Fibroblast spreading and proliferation on hydrophilic and hydrophobic surfaces is related to tyrosine phosphorylation in focal contacts. J Biomater Sci Polym Ed 1995, 7(3):297-305.
45. Keselowsky B.G., Collard D.M., Garcia A.J. Surface chemistry modulates focal adhesion composition and signaling through changes in integrin binding. Biomaterials 2004, 25(28):5947-5954.
46. Arima Y., Iwata H. Effect of wettability and surface functional groups on protein adsorption and cell adhesion using well-defined mixed self-assembled monolayers. Biomaterials 2007, 28(20):3074-3082.
47. Sastry S.K., Burridge K. Focal adhesions: a nexus for intracellular signaling and cytoskeletal dynamics. Exp Cell Res 2000, 261(1):25-36.
48. Garcia A.J., Boettiger D. Integrin-fibronectin interactions at the cell-material interface: initial integrin binding and signaling. Biomaterials 1999, 20(23-24):2427-2433.
49. Toworfe G.K., Composto R.J., Adams C.S., Shapiro I.M., Ducheyne P. Fibronectin adsorption on surface-activated poly(dimethylsiloxane) and its effect on cellular function. J Biomed Mater Res A 2004, 71(3):449-461.
50. Yeung T., Georges P.C., Flanagan L.A., Marg B., Ortiz M., Funaki M., et al. Effects of substrate stiffness on cell morphology, cytoskeletal structure, and adhesion. Cell Motil Cytoskeleton 2005, 60(1):24-34.
51. Grichnik J.M., Burch J.A., Schulteis R.D., Shan S., Liu J., Darrow T.L., et al. Melanoma, a tumor based on a mutant stem cell?. J Invest Dermatol 2006, 126(1):142-153.
52. Klein W.M., Wu B.P., Zhao S., Wu H., Klein-Szanto A.J., Tahan S.R. Increased expression of stem cell markers in malignant melanoma. Mod Pathol 2007, 20(1):102-107.
53. Roesch A., Fukunaga-Kalabis M., Schmidt E.C., Zabierowski S.E., Brafford P.A., Vultur A., et al. A temporarily distinct subpopulation of slow-cycling melanoma cells is required for continuous tumor growth. Cell 2010, 141(4):583-594.
54. Lin R.Z., Chang H.Y. Recent advances in three-dimensional multicellular spheroid culture for biomedical research. Biotechnol J 2008, 3(9-10):1172-1184.
55. Yamada K.M., Cukierman E. Modeling tissue morphogenesis and cancer in 3D. Cell 2007, 130(4):601-610.
56. Na Y.R., Seok S.H., Kim D.J., Han J.H., Kim T.H., Jung H., et al. Isolation and characterization of spheroid cells from human malignant melanoma cell line WM-266-4. Tumour Biol 2009, 30(5-6):300-309.
57. Agastin S., Giang U.-B.T., Geng Y., DeLouise L.A., King M.R. Continuously perfused microbubble array for 3D tumor spheroid model. Biomicrofluidics 2011, 5(2):024110.